Assessment of Muscle Thickness in Patients With Fibromyalgia
1 other identifier
interventional
60
1 country
1
Brief Summary
To investigate the muscle thickness in patients with fibromyalgia (FMS) and whether there is an increase in muscle thickness, strength, and function with stretching and strengthening exercise therapy in FMS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2024
CompletedFirst Submitted
Initial submission to the registry
January 24, 2024
CompletedFirst Posted
Study publicly available on registry
February 12, 2024
CompletedFebruary 14, 2024
February 1, 2024
7 months
January 24, 2024
February 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle thickness
Muscle thickness was measured with ultrasound (6-12 Megahertz: Philips purewave, multi-frequency linear probe). The anterior thigh muscle thicknesses were evaluated on quadriceps femoris. The midpoint between the upper end of the patella and the anterior iliac anterior superior iliac spine has been determined while the patients were lying on their backs and the muscle thickness is measured from this point in centimeters. Measurements were made three times in order to avoid erroneous measurements. All measurements were performed by a single physician, who had experience in musculoskeletal US.
at the beginning of the study and again at the end of 12 weeks by the same physician.
Secondary Outcomes (5)
pain level
at the beginning of the study and again at the end of 12 weeks by the same physician.
grip strength
at the beginning of the study and again at the end of 12 weeks by the same physician.
Physical performance
at the beginning of the study and again at the end of 12 weeks by the same physician.
Disease activity
at the beginning of the study and again at the end of 12 weeks by the same physician.
walking speed
at the beginning of the study and again at the end of 12 weeks by the same physician.
Study Arms (2)
Exercise group
ACTIVE COMPARATORThe exercise group was received a home exercise program consist of stretching and strengthening exercises, which was demonstrated by a physiotherapist and supported by visual cards. The exercises were shown to the patients in practice for at least 5 repetitions three days a week for 12 weeks. The exercise tracking form was given to the patients. The patients were called by the physiotherapist every week by telephone, and were allowed to fill out the exercise tracking form and adapt to exercise. Once every four weeks, patients were called to the hospital a total of three times and exercises were shown again in practice. Exercises started with stretching exercises; for ten seconds for three times with ten seconds of rest between each exercise. After stretching exercises extremity strengthening exercises were practiced with half-kilogram weights for the upper and lower extremities, each exercise is performed ten times with ten seconds of rest.
Control group
ACTIVE COMPARATORThe control group was told to exercise freely and without supervision. They were advised to exercise regularly, only verbally.
Interventions
Eligibility Criteria
You may qualify if:
- female patients
- aged 18 to 65 years
- who were diagnosed with FMS according to the 2016 American College of Rheumatology (ACR) classification criteria
You may not qualify if:
- Patients who have a neurological or orthopedic disease that will prevent ambulation,
- advanced heart failure, kidney failure, liver failure, pulmonary diseases that will prevent exercise,
- inflammatory rheumatoid disease,
- pregnancy, breastfeeding, malignancy, psychiatric illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hitit Universitylead
Study Sites (1)
Hitit University
Çorum, 19040, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
MUSTAFA KESER
HİTİT UNİVERSİTY EROL OLÇOK RESEARCH HOSPİTAL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Participants: Patients with fibromyalgia Care provider: Physiotherapist who showed and followed the patients exercise programme Researchers were blinded to the patients groups
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 24, 2024
First Posted
February 12, 2024
Study Start
June 14, 2023
Primary Completion
January 20, 2024
Study Completion
January 20, 2024
Last Updated
February 14, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
Due to the confidentiality of personal data